These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 18304679

  • 21. Review article: diagnosis and treatment of non-alcoholic fatty liver disease.
    Oh MK, Winn J, Poordad F.
    Aliment Pharmacol Ther; 2008 Sep 01; 28(5):503-22. PubMed ID: 18532991
    [Abstract] [Full Text] [Related]

  • 22. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG.
    J Dig Dis; 2008 May 01; 9(2):63-7. PubMed ID: 18419637
    [Abstract] [Full Text] [Related]

  • 23. Hypertension and fatty liver: guilty by association?
    Brookes MJ, Cooper BT.
    J Hum Hypertens; 2007 Apr 01; 21(4):264-70. PubMed ID: 17273155
    [Abstract] [Full Text] [Related]

  • 24. Pathologic assessment of non-alcoholic fatty liver disease.
    Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM.
    Clin Liver Dis; 2007 Feb 01; 11(1):17-23, vii. PubMed ID: 17544969
    [Abstract] [Full Text] [Related]

  • 25. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C, Girard J.
    Diabetes Metab; 2008 Dec 01; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [Abstract] [Full Text] [Related]

  • 26. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E.
    Minerva Gastroenterol Dietol; 2008 Mar 01; 54(1):7-18. PubMed ID: 18299664
    [Abstract] [Full Text] [Related]

  • 27. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N, Younossi ZM.
    Clin Liver Dis; 2009 May 01; 13(2):249-66. PubMed ID: 19442917
    [Abstract] [Full Text] [Related]

  • 28. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S.
    Scand J Gastroenterol; 2009 May 01; 44(3):366-74. PubMed ID: 19016382
    [Abstract] [Full Text] [Related]

  • 29. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM, Ostapowicz G, Weltman MD.
    J Gastroenterol Hepatol; 2009 Feb 01; 24(2):243-7. PubMed ID: 19215335
    [Abstract] [Full Text] [Related]

  • 30. Nonalcoholic fatty liver disease.
    Adams LA, Angulo P, Lindor KD.
    CMAJ; 2005 Mar 29; 172(7):899-905. PubMed ID: 15795412
    [Abstract] [Full Text] [Related]

  • 31. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.
    Akbar DH, Kawther AH.
    Med Sci Monit; 2006 Jan 29; 12(1):RA23-6. PubMed ID: 16369477
    [Abstract] [Full Text] [Related]

  • 32. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D, Sattar N.
    Clin Sci (Lond); 2008 Sep 29; 115(5):141-50. PubMed ID: 18662168
    [Abstract] [Full Text] [Related]

  • 33. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
    Lebovics E, Rubin J.
    Diabetes Metab Res Rev; 2011 Jul 29; 27(5):419-24. PubMed ID: 21425426
    [Abstract] [Full Text] [Related]

  • 34. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK.
    Am J Gastroenterol; 2009 Apr 29; 104(4):861-7. PubMed ID: 19293782
    [Abstract] [Full Text] [Related]

  • 35. Fatty liver: a novel component of the metabolic syndrome.
    Kotronen A, Yki-Järvinen H.
    Arterioscler Thromb Vasc Biol; 2008 Jan 29; 28(1):27-38. PubMed ID: 17690317
    [Abstract] [Full Text] [Related]

  • 36. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L, Lemoine M.
    Diabetes Metab; 2008 Dec 29; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [Abstract] [Full Text] [Related]

  • 37. Nonalcoholic fatty liver disease.
    Hjelkrem MC, Torres DM, Harrison SA.
    Minerva Med; 2008 Dec 29; 99(6):583-93. PubMed ID: 19034256
    [Abstract] [Full Text] [Related]

  • 38. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis.
    Loria P, Lonardo A, Targher G.
    Clin Sci (Lond); 2008 Jul 29; 115(1):1-12. PubMed ID: 19016656
    [Abstract] [Full Text] [Related]

  • 39. Nonalcoholic fatty liver disease in India--is it different?
    Duseja A.
    Trop Gastroenterol; 2006 Jul 29; 27(4):142-6. PubMed ID: 17542290
    [Abstract] [Full Text] [Related]

  • 40. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A, Trappoliere M, Loguercio C.
    Dig Liver Dis; 2006 Nov 29; 38(11):789-801. PubMed ID: 16750661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.